Article

Machine learning-based proteogenomic data modeling identifies circulating plasma biomarkers for early detection of lung cancer

2024-08-01

Abstract excerpt

Identifying genetic variants associated with lung cancer (LC) risk and their impact on plasma protein levels is crucial for understanding LC predisposition. The discovery of risk biomarkers can enhance early LC screening protocols and improve prognostic interventions. In this study, we performed a genome-wide association analysis using the UK Biobank and FinnGen. We identified genetic variants associated with LC a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3626bcd2-793d-5a52-9c7a-8ab211084078
DOI: 10.1101/2024.07.30.24311241

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Machine learning-based proteogenomic data modeling identifies circulating plasma biomarkers for early detection of lung cancerDOI 10.1101/2024.07.30.24311241Read

Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.Semantic proximity Read

Integrating genomics and proteomics data to identify candidate plasma biomarkers for lung cancer risk among European descendants.Semantic proximity Read

Multi-omics profiling with untargeted proteomics for blood-based early detection of lung cancerSemantic proximity Read

Plasma proteomic profiles predict chronic obstructive pulmonary disease up to 16 years before onset: a multi-national, machine learning-guided biomarker discovery studySemantic proximity Read

Identification of promising lung cancer drug targets from human plasma proteins: Mendelian randomization, single-cell RNA sequencing analysisSemantic proximity Read

Unveiling the potential of proteomic and genetic signatures for precision therapeutics in lung cancer managementSemantic proximity Read

Identifying proteomic risk factors for cancer using prospective and exome analyses: 1,463 circulating proteins and risk of 19 cancers in the UK BiobankSemantic proximity Read

Identifying proteomic risk factors for cancer using prospective and exome analyses of 1463 circulating proteins and risk of 19 cancers in the UK Biobank.Semantic proximity Read

Potential of Protein Risk Signatures in Lung Adenocarcinoma: A Comprehensive Bioinformatics StudySemantic proximity Read

Integration of lung tissue proteomics and genome-wide association data to identify lung cancer susceptibility proteins and potential drug targetsSemantic proximity Read

A Peripheral Blood Transcriptomic Biomarker Panel Identified by Multiple Machine Learning Algorithms Enables Early Diagnosis and Prognosis Prediction in Lung CancerSemantic proximity Read

Circulating Proteome for Pulmonary Nodule MalignancySemantic proximity Read